SK284610B6 - Vakcína obsahujúca nevirulentný, neopuzdrený geneticky modifikovaný Actinobacillus pleuropneumoniae a spôsob jej výroby - Google Patents

Vakcína obsahujúca nevirulentný, neopuzdrený geneticky modifikovaný Actinobacillus pleuropneumoniae a spôsob jej výroby Download PDF

Info

Publication number
SK284610B6
SK284610B6 SK1771-98A SK177198A SK284610B6 SK 284610 B6 SK284610 B6 SK 284610B6 SK 177198 A SK177198 A SK 177198A SK 284610 B6 SK284610 B6 SK 284610B6
Authority
SK
Slovakia
Prior art keywords
pleuropneumoniae
dna
fragment
vaccine
serotype
Prior art date
Application number
SK1771-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK177198A3 (en
Inventor
Thomas J. Inzana
Christine Ward
Original Assignee
Virginia Tech Intellectual Properties, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties, Inc filed Critical Virginia Tech Intellectual Properties, Inc
Publication of SK177198A3 publication Critical patent/SK177198A3/sk
Publication of SK284610B6 publication Critical patent/SK284610B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SK1771-98A 1996-06-27 1997-06-17 Vakcína obsahujúca nevirulentný, neopuzdrený geneticky modifikovaný Actinobacillus pleuropneumoniae a spôsob jej výroby SK284610B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/673,814 US6086894A (en) 1996-06-27 1996-06-27 Recombinant vaccine for diseases caused by encapsulated organisms
PCT/US1997/010236 WO1997049416A1 (en) 1996-06-27 1997-06-17 Recombinant vaccine for diseases caused by encapsulated organisms

Publications (2)

Publication Number Publication Date
SK177198A3 SK177198A3 (en) 2000-03-13
SK284610B6 true SK284610B6 (sk) 2005-07-01

Family

ID=24704213

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1771-98A SK284610B6 (sk) 1996-06-27 1997-06-17 Vakcína obsahujúca nevirulentný, neopuzdrený geneticky modifikovaný Actinobacillus pleuropneumoniae a spôsob jej výroby

Country Status (19)

Country Link
US (2) US6086894A (es)
EP (1) EP0964689A4 (es)
JP (1) JP2001522347A (es)
CN (1) CN1092069C (es)
AR (1) AR008615A1 (es)
AU (1) AU734254B2 (es)
BR (1) BR9710986A (es)
CA (1) CA2258168A1 (es)
CZ (1) CZ295438B6 (es)
HK (1) HK1020004A1 (es)
NO (1) NO986099L (es)
NZ (1) NZ333387A (es)
PL (1) PL186728B1 (es)
RU (1) RU2234941C2 (es)
SK (1) SK284610B6 (es)
TR (1) TR199802716T2 (es)
UA (1) UA70287C2 (es)
WO (1) WO1997049416A1 (es)
ZA (1) ZA975586B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138803A0 (en) * 1998-04-02 2001-10-31 Univ Oklahoma Nucleic acid encoding hyaluronan synthase
US7708642B2 (en) 2001-10-15 2010-05-04 Igt Gaming device having pitch-shifted sound and music
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
EP1914239B1 (en) * 2002-04-05 2010-06-09 Merial Attentuated gram negative bacteria
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
PT1638598E (pt) * 2003-07-02 2007-03-30 Biotechnology Res & Dev Mutantes acapsulares de deleção de hyae de p. multocida
JP5808671B2 (ja) * 2008-11-10 2015-11-10 ノヴォ ノルディスク アー／エス 機能グループｉｉ莢膜遺伝子クラスターを有しないｅ．ｃｏｌｉｂｌ２１株
TWI548746B (zh) * 2009-08-06 2016-09-11 英特威特國際股份有限公司 防備豬胸膜肺炎之疫苗及製備該疫苗之方法
CN106866800B (zh) * 2016-09-14 2020-08-18 四川农业大学 胸膜肺炎放线杆菌的体内诱导抗原及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US549818A (en) * 1895-11-12 Rolling-mill
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
WO1993010815A1 (en) * 1991-12-06 1993-06-10 Center For Innovated Technology Non-capsulated mutants of bacteria useful as vaccines
JP2717481B2 (ja) * 1992-08-25 1998-02-18 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料

Also Published As

Publication number Publication date
NZ333387A (en) 2000-06-23
PL186728B1 (pl) 2004-02-27
TR199802716T2 (xx) 2001-06-21
CA2258168A1 (en) 1997-12-31
PL330863A1 (en) 1999-06-07
AR008615A1 (es) 2000-02-09
NO986099D0 (no) 1998-12-23
NO986099L (no) 1999-01-13
SK177198A3 (en) 2000-03-13
CZ418998A3 (cs) 1999-07-14
CN1223586A (zh) 1999-07-21
CZ295438B6 (cs) 2005-08-17
BR9710986A (pt) 2001-12-11
EP0964689A1 (en) 1999-12-22
HK1020004A1 (en) 2000-03-10
EP0964689A4 (en) 2004-09-08
US6326001B1 (en) 2001-12-04
UA70287C2 (en) 2004-10-15
AU3390497A (en) 1998-01-14
CN1092069C (zh) 2002-10-09
US6086894A (en) 2000-07-11
WO1997049416A1 (en) 1997-12-31
JP2001522347A (ja) 2001-11-13
RU2234941C2 (ru) 2004-08-27
ZA975586B (en) 1998-03-23
AU734254B2 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
Barry et al. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation
HU228700B1 (en) Streptococcus suis vaccines and diagnostic tests
US5843444A (en) Conjugate vaccine for group B streptococcus
Ward et al. Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a: concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A. pleuropneumoniae serotype 1
US20080241181A1 (en) Environmentally regulated genes of Streptococcus suis
JPH11504662A (ja) アクチノバチラス・プレウロニューモニエに対するワクチンとしてのリボフラビン変異体
EP0656014B1 (en) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
KR100349331B1 (ko) 비(b)군연쇄상구균에대한접합백신
Bandara et al. Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs
Shimoji et al. Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn 916 to inactivate a target gene
JP3388171B2 (ja) 淋菌ｐｉタンパク質およびワクチンの製造
SK284610B6 (sk) Vakcína obsahujúca nevirulentný, neopuzdrený geneticky modifikovaný Actinobacillus pleuropneumoniae a spôsob jej výroby
WO2006130925A1 (en) Genetic manipulation of clostridium difficile
JP2001510342A (ja) 新規微生物
AU743654B2 (en) LKTA deletion mutant of P. haemolytica
KR20000049090A (ko) 헬리코박터 필로리 생백신
US6403306B1 (en) Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
US7541447B2 (en) Process for the preparation of an improved Brucella strain plasmid to develop the strain and the vaccine comprising the said strain
CN108671227A (zh) 一种预防猪链球菌感染的广谱多联亚单位疫苗
JPH0284183A (ja) ボルデテラ・ペルタシスワクチン
JPH09501308A (ja) 接触仲介性溶血素のレギュレーター
KR100567351B1 (ko) 피낭형세균에의해유발되는질병에대한재조합백신
US5895756A (en) Non-antibiotic system for selection of recombinant mycobacteria
WO2004089408A2 (en) Vaccine preparations comprising live or killed attenuated mutant neisseria bacteria
Guidolin Molecular biology of" Vibrio cholerae" bacteriophage CP-T1 and its host interactions